Related Experiment Video
Updated: Oct 9, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer
L Garland1, L A Robinson, H Wagner
1Thoracic Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida, USA.
Chest Surgery Clinics of North America
|March 20, 2001
Abstract:
Management of the stage IIIA (N2) patient remains one of the most controversial areas in thoracic oncology. The potential curability of at least some of these patients has encouraged the development of more complex, aggressive, and toxic multimodality treatment regimens.